SUVEN LIFE SCIENCES
Back to Balance Sheet
|
SUVEN LIFE SCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹23 Cr | ₹14 Cr | ₹105 Cr | ₹102 Cr | ₹110 Cr |
What is the latest Total Current Liabilities ratio of SUVEN LIFE SCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹23 Cr |
| Mar2024 | ₹14 Cr |
| Mar2023 | ₹105 Cr |
| Mar2022 | ₹102 Cr |
| Mar2021 | ₹110 Cr |
How is Total Current Liabilities of SUVEN LIFE SCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹23 Cr | 73.76 | |
| Mar2024 | ₹14 Cr | -87.13 | |
| Mar2023 | ₹105 Cr | 2.75 | |
| Mar2022 | ₹102 Cr | -6.92 | |
| Mar2021 | ₹110 Cr | - | |
Compare Total Current Liabilities of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹3,193.5 Cr | 4.3% | -16.7% | 20.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹390,828.0 Cr | 1.2% | -5.3% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,227.0 Cr | -3.9% | -6% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,045.0 Cr | 0.9% | 3.7% | 20.5% | Stock Analytics | |
| CIPLA | ₹105,961.0 Cr | -1.2% | -12.6% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,682.5 Cr | -3.4% | -5.7% | 0.3% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | 4.3% |
-16.7% |
20.8% |
| SENSEX | -0.2% |
-4.2% |
8.4% |
You may also like the below Video Courses